Rubler S, Arvan S B, Rafii F, Shah N, Olowe O
Angiology. 1977 Oct;28(10):702-11. doi: 10.1177/000331977702801007.
Diastolic and systolic time intervals were measured in 11 control subjects, 11 patients with cardiomyopathy, 7 hyperthyroid patients, and 5 hypothyroid patients. The isovolumic relaxation time (IVRT), rapid filling time (RFT), preejection period (PEP), left ventricular ejection time (LVET), and PEP/LVET ratio were found by simultaneously recording the ECG, phonocardiogram, external carotid pulse, and apexcardiogram. In cardiomyopathy the IVRT and RFT were prolonged (107.4 +/- 21.1 msec [P less than 0.01] and 111.0 +/- 10.0 [P less than 0.01] respectively) in comparison to the control subjects. (In the controls the IVRT was 85.7 +/- 18.4 msec and the RFT was 94.5 +/- 12.8 msec). In altered thyroid states the RFT was most affected; in hypothyroidism it increased to 123.9 +/- 25.2 (P less than 0.01) and in hyperthyroidism it decreased to 71.5 +/- 21.3 msec (P less than 0.01). In hyperthyroid patients the IVRT, although shorter than in control subjects, was not significantly altered, but it showed a significant increase after treatment. The RFT also returned toward normal after therapy in both groups (116.7 +/- 14.6 msec in hypothyroid patients and 89.0 +/- 23.1 msec in those with hyperthyroidism).
对11名对照受试者、11名心肌病患者、7名甲状腺功能亢进患者和5名甲状腺功能减退患者测量了舒张期和收缩期时间间隔。通过同步记录心电图、心音图、颈外动脉脉搏和心尖搏动图,得出等容舒张时间(IVRT)、快速充盈时间(RFT)、射血前期(PEP)、左心室射血时间(LVET)以及PEP/LVET比值。与对照受试者相比,心肌病患者的IVRT和RFT延长(分别为107.4±21.1毫秒[P<0.01]和111.0±10.0[P<0.01])。(对照受试者的IVRT为85.7±18.4毫秒,RFT为94.5±12.8毫秒)。在甲状腺状态改变时,RFT受影响最大;甲状腺功能减退时,RFT增加到123.9±25.2(P<0.01),甲状腺功能亢进时,RFT减少到71.5±21.3毫秒(P<0.01)。甲状腺功能亢进患者的IVRT虽然比对照受试者短,但无明显改变,但治疗后显著增加。两组治疗后RFT也恢复正常(甲状腺功能减退患者为116.7±14.6毫秒,甲状腺功能亢进患者为89.0±23.1毫秒)。